1. The protective effects of resveratrol pretreatment in cyclophosphamide-induced rat ovarian injury: an vivo study
- Author
-
Chunfang Zhao, Wei Wang, Yanan Zhang, Haifeng Wu, Zhao-Yan Nie, Lei Zhang, Wei Chen, Gong Miao, Tiantian Zhang, and Rui Hua
- Subjects
Anti-Mullerian Hormone ,endocrine system diseases ,Cyclophosphamide ,Endocrinology, Diabetes and Metabolism ,Rat model ,Ovary ,Resveratrol ,Pharmacology ,Rats, Sprague-Dawley ,chemistry.chemical_compound ,Follicle ,Endocrinology ,Sirtuin 1 ,medicine ,Animals ,Ovarian Diseases ,Antineoplastic Agents, Alkylating ,business.industry ,Forkhead Box Protein O3 ,Fertility Preservation ,Obstetrics and Gynecology ,Ovarian toxicity ,Rats ,medicine.anatomical_structure ,chemistry ,Apoptosis ,Female ,Tumor Suppressor Protein p53 ,business ,medicine.drug - Abstract
To explore whether resveratrol (Res) pretreatment could exert a protective effect on cyclophosphamide (Cy) induced ovarian toxicity in a rat model.Twenty-four female 7-week old Sprague-Dawley rats were randomly divided into four groups: Con, administered with vehicle solutions; Cy, treated with Cy; Res + Cy, treated with Cy + Res combined; Res, treated with Res. After 21 d of treatments, the rats were euthanized and blood samples were collected to evaluate the levels of anti-Müllerian hormone (AMH). The Ovaries were processed for immunohistochemical and western blotting.Cy-treat caused the decrease of body weights and ovarian weight. AMH was lower in Cy group, whereas AMH levels were similar among other groups. Histomorphology showed a large number of primordial follicles were activated in Cy groups, whereas the primordial follicles were inhibited in the Res and Res + Cy groups. The expressions of Sirt1, Foxo3a were up-regulated and p53, Caspase-3, and Bax were down-regulated in Res + Cy and Res groups (Res can prevent the primordial follicle activation and decrease apoptosis induced by Cy. Res may be an effective protection for ovarian function during chemotherapy, which means a new nonsurgical application for protection of ovarian reserve.
- Published
- 2021